Codexis, Inc. (CDXS)
()
 
 

Overview

Codexis, Inc. is a leading provider of optimized biocatalysts that make existing industrial processes faster, cleaner and more efficient than current methods and have the potential to make new industrial processes possible at commercial scale. Codexis has commercialized its biocatalysts in the pharmaceutical industry and is developing biocatalysts for use in producing advanced biofuels under a multi-year research and development collaboration. The company is also using its technology platform to pursue biocatalyst-enabled solutions in other bioindustrial markets, including carbon management, water treatment and chemicals.


Contact Information

200 Penobscot Drive
Redwood City, CA 94063

tel: 650-421-8100
fax: 650-421-8134
http://www.codexis.com

,  



Investor Relations


Derick Sutton
tel: 650-421-8130
fax:
e-mail: derick.sutton@codexis.com




Stock

Exchange: NASDAQ
Industry: Biotechnology
Market Cap: $325M




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.